M&A Deal Summary

Bausch Health Acquires Solta Medical

On December 16, 2013, Bausch Health acquired medical products company Solta Medical for 250M USD

Acquisition Highlights
  • This is Bausch Health’s 3rd transaction in the Medical Products sector.
  • This is Bausch Health’s 18th largest (disclosed) transaction.
  • This is Bausch Health’s 13th transaction in the United States.
  • This is Bausch Health’s 5th transaction in California.

M&A Deal Summary
Date 2013-12-16
Target Solta Medical
Sector Medical Products
Buyer(s) Bausch Health
Deal Type Add-on Acquisition
Deal Value 250M USD
Advisor(s) Piper Jaffray Companies (Financial)
Fenwick & West LLP (Legal)

Target

Solta Medical

Hayward, California, United States
website
Solta Medical, Inc. is a designer, developer, manufacturer and marketer of medical devices for the non-invasive treatment of wrinkles.

Search 193,092 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bausch Health

Laval, Quebec, Canada

website

Category Company
Sector Life Science
Employees19,900
Revenue 8.1B USD (2022)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.

DEAL STATS #
Overall 25 of 35
Sector (Medical Products) 3 of 6
Type (Add-on Acquisition) 18 of 25
State (California) 5 of 6
Country (United States) 13 of 22
Year (2013) 4 of 4
Size (of disclosed) 18 of 27
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-11-01 Valeant Pharmaceuticals Caladryl

India

Valeant Pharmaceuticals Caladryl is an anti-pruritic solution known for dermatosis application for minor skin irritations and itching.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-03 PreCision Dermatology

Cumberland, Rhode Island, United States

PreCision Dermatology, Inc. is a specialty pharmaceutical company developing, manufacturing and marketing prescription and consumer dermatology products. Our mission is to develop innovative skincare therapies with proven clinical performance that patients prefer and physicians are confident to prescribe.

Buy $475M
Mergr

Product

Company

Legal